Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Related Articles by Review for PubMed (Select 16155611)

1.

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy.

Taylor GP, Matsuoka M.

Oncogene. 2005 Sep 5;24(39):6047-57. Review.

PMID:
16155611
2.
3.
4.

Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.

Bazarbachi A, Hermine O.

Virus Res. 2001 Oct 30;78(1-2):79-92. Review.

PMID:
11520582
5.

Tumor immunity against adult T-cell leukemia.

Kannagi M, Harashima N, Kurihara K, Ohashi T, Utsunomiya A, Tanosaki R, Masuda M, Tomonaga M, Okamura J.

Cancer Sci. 2005 May;96(5):249-55. Review.

PMID:
15904464
6.

Treatment of adult T-cell leukemia/lymphoma: past, present, and future.

Ishitsuka K, Tamura K.

Eur J Haematol. 2008 Mar;80(3):185-96. Epub 2007 Dec 10. Review.

PMID:
18081707
7.

Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?

Barbeau B, Mesnard JM.

Int Rev Immunol. 2007 Sep-Dec;26(5-6):283-304. Review.

PMID:
18027202
8.

Adult T-cell leukemia/lymphoma and HTLV-1.

Mahieux R, Gessain A.

Curr Hematol Malig Rep. 2007 Oct;2(4):257-64. doi: 10.1007/s11899-007-0035-x. Review.

PMID:
20425378
9.

Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.

Franchini G, Nicot C, Johnson JM.

Adv Cancer Res. 2003;89:69-132. Review.

PMID:
14587871
10.

Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches.

Tanosaki R, Tobinai K.

Expert Rev Hematol. 2010 Dec;3(6):743-53. doi: 10.1586/ehm.10.73. Review.

PMID:
21091150
11.

The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.

Murata K, Yamada Y.

Int Rev Immunol. 2007 Sep-Dec;26(5-6):249-68. Review.

PMID:
18027200
12.

Current status of therapeutic approaches to adult T-cell leukemia.

Ishikawa T.

Int J Hematol. 2003 Nov;78(4):304-11. Review.

PMID:
14686487
13.

Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.

Tobinai K.

Semin Hematol. 2010 Apr;47 Suppl 1:S5-7. doi: 10.1053/j.seminhematol.2010.01.015. Review.

PMID:
20359583
14.

Potential for molecular targeted therapy for adult T-cell leukemia/lymphoma.

Faris M.

Int Rev Immunol. 2008 Jan-Apr;27(1-2):71-8. doi: 10.1080/08830180701777475. Review.

PMID:
18300056
15.

Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia.

Kannagi M.

Int J Hematol. 2007 Aug;86(2):113-7. Review.

PMID:
17875523
16.

Therapeutic options for adult T-cell leukemia/lymphoma.

Marçais A, Suarez F, Sibon D, Frenzel L, Hermine O, Bazarbachi A.

Curr Oncol Rep. 2013 Oct;15(5):457-64. doi: 10.1007/s11912-013-0332-6. Review.

PMID:
23943384
17.

Human T-cell lymphotropic-I-associated leukemia/lymphoma.

Siegel RS, Gartenhaus RB, Kuzel TM.

Curr Treat Options Oncol. 2001 Aug;2(4):291-300. Review.

PMID:
12057109
18.

HTLV-1 Tax and adult T-cell leukemia.

Giam CZ, Jeang KT.

Front Biosci. 2007 Jan 1;12:1496-507. Review.

PMID:
17127397
19.

HBZ, a new important player in the mystery of adult T-cell leukemia.

Mesnard JM, Barbeau B, Devaux C.

Blood. 2006 Dec 15;108(13):3979-82. Epub 2006 Aug 17. Review.

20.

Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.

Bazarbachi A, Hermine O.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S186-90. Review.

PMID:
8797722
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk